Volunteer Facilitated Discharge Assistance and Supports at Home (DASH) for People With Stroke (DASH)
15. mai 2026 oppdatert av: Bruyère Health Research Institute.
Volunteer Facilitated Discharge Assistance and Supports at Home (DASH) for People With Stroke: An Effectiveness-implementation Hybrid Trial.
The goal of this clinical trial is to learn if a home visit by a trained volunteer can improve stroke recovery after a stroke survivor is discharged home from the hospital. The main questions it aims to answer are:
- After 3 months of being discharged from the hospital, does this additional volunteer support at home improve coping skills for stroke survivors?
- Does the effects of the volunteer support last over 3 to 6 months after being discharged home?
Researchers will compare between a group who will receive the volunteer support and a group who will not to see if the additional support can improve stroke recovery.
Participants will:
- Either receive volunteer support over an 8-week time period OR receive no additional volunteer support
- Continue with their usual care plan and receive educational resources from the research team during the study
- Complete online surveys during study enrollment, at 3 months, and at 6 months after hospital discharge
Studieoversikt
Status
Har ikke rekruttert ennå
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Acute stroke often leads to adult disability in Canada, and about 108,707 Canadians experience a stroke each year.
While most people survive stroke (80 percent) and return home, some survivors are left with ongoing challenges that require them to seek help in the community.
These challenges can lead to stress for the individual and their caregiver.
Research on volunteer-supported home-to-hospital programs has shown positive outcomes.
However, despite the growing evidence that supports volunteer engagement in care transitions, we have yet to determine the impact of a complex psychosocial volunteer-delivered care transition intervention for stroke survivors.
This study will assess whether a volunteer-delivered transitional care intervention, designed by Bruyère Health Research Institute in partnership with March of Dimes Canada (MODC), for adults discharged home from a stroke rehabilitation unit following an acute stroke can improve coping compared to usual care.
MODC will implement the volunteer-support transition program across two Ontario regions for stroke rehabilitation sites.
Those allocated to the intervention group will receive an initial visit from the Volunteer Coordinator and then weekly one-on-one visits by a trained volunteer for eight weeks.
The volunteer may assist the study participant with instrumental daily living activities and psychosocial and informational support.
Those not receiving the intervention will receive educational material at 4- and 8-week time points in addition to their usual care.
All study participants will complete validated patient-reported outcome measures at 3- and 6-months post-hospital discharge.
Studietype
Intervensjonell
Registrering (Antatt)
840
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Michelle LA Nelson, MA, PhD, FAHA, FWSO
- Telefonnummer: 647-938-4425
- E-post: mla.nelson@uottawa.ca
Studer Kontakt Backup
- Navn: Research Coordinator
- E-post: TMoni@bruyere.org
Studiesteder
-
-
Ontario
-
Ottawa, Ontario, Canada
- Bruyère Health Élisabeth-Bruyère Hospital
-
Toronto, Ontario, Canada
- Sunnybrook Health Sciences Centre
-
Toronto, Ontario, Canada
- Hennick Bridgepoint Hospital
-
Toronto, Ontario, Canada
- Providence Healthcare (Unity Health Toronto)
-
Toronto, Ontario, Canada
- Toronto Rehabilitation Institute (UHN)
-
Toronto, Ontario, Canada
- West Park Healthcare Centre (UHN)
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Nei
Beskrivelse
Inclusion Criteria:
- Confirmed diagnosis of stroke
- Either undergoing or recently completed in-patient rehabilitation within the last 3 weeks
- Lived at home pre-stroke
- Discharged directly home (to own residence or that of a family member)
- Live in one of the program implementation areas (i.e., Toronto, Ottawa)
Exclusion Criteria:
- Discharged to additional hospital inpatient care, nursing home, or other long-term care
- Inability to communicate in English
- Inability to provide informed consent due to cognitive deficits
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Group A: DASH group
Participants will receive the DASH intervention + Usual Care + Educational Resources
|
One-on-one weekly visits in the stroke survivor participants' residence by a trained volunteer for approximately 8 weeks (about 2 months). Volunteer support could span three types: i) instrumental activities of daily living assistance (e.g., assistance with meal preparation, light house duties, and transportation), ii) psychosocial support (e.g., befriending visits), and iii) informational supports (signposting to other community services). |
|
Ingen inngripen: Group B: Usual care group
Participants will receive the Usual Care + Educational Resources
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Coping at Time 1 as assessed by Post-Discharge Coping Difficulty Scale (PDCDS)
Tidsramme: Measured at 3 months post-hospital discharge
|
Coping will be assessed using the Post-Discharge Coping Difficulty Scale (PDCDS), a 10-item patient-reported outcome measure evaluating perceived difficulty coping following hospital discharge.
Each item is scored on a scale from 0 to 10. Item scores are summed to yield a total score ranging from 0 to 100, with higher scores indicating greater difficulty coping.
|
Measured at 3 months post-hospital discharge
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change in coping as assessed by Post-Discharge Coping Difficulty Scale (PDCDS)
Tidsramme: Measured at 3 months and 6 months post-hospital discharge
|
Coping will be assessed using the Post-Discharge Coping Difficulty Scale (PDCDS), a 10-item patient-reported measure.
Each item is scored from 0 to 10, with total scores ranging from 0 to 100.
Change in total score will be calculated between time points.
Higher scores indicate greater difficulty coping.
|
Measured at 3 months and 6 months post-hospital discharge
|
|
Change in quality of life as assessed by Stroke-Specific Quality of Life (SS-QOL)
Tidsramme: Measured at 3 months and 6 months post-hospital discharge
|
Quality of life will be assessed using the Stroke-Specific Quality of Life (SS-QOL) scale, a 49-item patient-reported measure evaluating multiple domains of health-related quality of life in stroke survivors.
Each item is scored on a 5-point Likert scale (1 to 5).
Domain scores are calculated as the average of items within each domain, and the overall score is calculated as the average of all domain scores or as the sum of all 49 items (ranging 49 to 245).
Higher scores indicate better quality of life.
|
Measured at 3 months and 6 months post-hospital discharge
|
|
Change in symptoms of depression as assessed by Patient Health Questionnaire-9 (PHQ-9)
Tidsramme: Measured at 3 months and 6 months post-hospital discharge
|
Depressive symptoms will be assessed using the Patient Health Questionnaire-9 (PHQ-9), a 9-item patient-reported measure.
Each item is scored from 0 to 3, resulting in a total score ranging from 0 to 27, with higher scores indicating greater severity of depressive symptoms.
|
Measured at 3 months and 6 months post-hospital discharge
|
|
Change in social isolation and loneliness indicators as assessed by UCLA Loneliness Scale (Version 3)
Tidsramme: Measured at 3 months and 6 months post-hospital discharge
|
Social isolation and loneliness will be assessed using the UCLA Loneliness Scale (Version 3), a 20-item patient-reported measure evaluating subjective feelings of loneliness and social isolation.
Each item is scored on a 4-point scale.
Total scores range from 20 to 80, with higher scores indicating greater loneliness.
|
Measured at 3 months and 6 months post-hospital discharge
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Antatt)
1. juni 2026
Primær fullføring (Antatt)
1. januar 2028
Studiet fullført (Antatt)
1. april 2028
Datoer for studieregistrering
Først innsendt
11. mai 2026
Først innsendt som oppfylte QC-kriteriene
11. mai 2026
Først lagt ut (Faktiske)
15. mai 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
18. mai 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
15. mai 2026
Sist bekreftet
1. mai 2026
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 191308
- 5161 (Annen identifikator: Clinical Trials Ontario)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
UBESLUTTE
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .